FP5Individual fellowship2000–2002
Tumour targeting with the antimitotic drug cryptophycin conjugated to peptides
FP5 — Improving Human Research Potential
- Duration
- 2000-10-01 → 2002-09-30
- EU contribution
- €147,400
- Participants
- 1
- Scheme
- RGI
Lines connect the coordinator with its partners.
Participants
- UNIVERSITY OF BIELEFELD · BIELEFELDCoordinatorGermany
Links
Data: CORDIS, © European Union